FDA Request For Clarifying DSHEA, Like Mandatory Listing, Splits US Supplement Industry Groups

Already differing on supporting FDA suggestion for mandatory annual registration of each VMS product sold in US, consumer health industry stakeholders’ schism now extends to agency suggestion that Congress clarify its regulatory authority over supplement manufacturing and marketing.

• Source: Alamy

More from Regulation

More from Policy & Regulation